These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8322261

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA, Molchanova LV, Kalishevskaia TM, Bazaz'ian GG, Pastorova VE, Sytina NP.
    Vopr Med Khim; 1969; 15(5):483-6. PubMed ID: 5368085
    [No Abstract] [Full Text] [Related]

  • 23. Defibrination and the hypercoagulable state: a model using papain in rabbits.
    Soong BC, Miller SP.
    Am J Physiol; 1972 May; 222(5):1113-20. PubMed ID: 5022370
    [No Abstract] [Full Text] [Related]

  • 24. Tumor cell prothrombotic properties.
    Falanga A.
    Haemostasis; 2001 May; 31 Suppl 1():1-4. PubMed ID: 11990464
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Acquired dysfibrinogenaemia.
    Francis JL, Armstrong DJ.
    Med Lab Sci; 1983 Apr; 40(2):165-75. PubMed ID: 6350786
    [No Abstract] [Full Text] [Related]

  • 29. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A, Marchetti M, Vignoli A, Balducci D.
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [Abstract] [Full Text] [Related]

  • 30. Comparative aspects of blood coagulation.
    Gentry PA.
    Vet J; 2004 Nov; 168(3):238-51. PubMed ID: 15501141
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Coagulation disorders in cancer patients: possible opportunity for therapy].
    Bom JB, Verheul HM, Hoekman K, Pinedo HM.
    Ned Tijdschr Geneeskd; 2000 Feb 05; 144(6):258-63. PubMed ID: 10687017
    [Abstract] [Full Text] [Related]

  • 33. Cancer and blood coagulation: molecular aspects.
    Bromberg ME, Cappello M.
    Cancer J Sci Am; 1999 Feb 05; 5(3):132-8. PubMed ID: 10367166
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
    Gerner C, Steinkellner W, Holzmann K, Gsur A, Grimm R, Ensinger C, Obrist P, Sauermann G.
    Thromb Haemost; 2001 Mar 05; 85(3):494-501. PubMed ID: 11307821
    [Abstract] [Full Text] [Related]

  • 38. [Contribution to the knowledge of the hemorrhagic syndrome induced by thrombin. Behavior of factors II, V and VII].
    Girolami A, Agostino D.
    Hemostase; 1965 Jun 05; 5(2):131-8. PubMed ID: 5850751
    [No Abstract] [Full Text] [Related]

  • 39. [Cancer procoagulant (CP)].
    Szajda SD, Darewicz B, Gorzel M, Zalewska B, Skrzydlewski Z, Kudelski J, Domel T.
    Przegl Lek; 2005 Jun 05; 62(3):169-72. PubMed ID: 16171148
    [Abstract] [Full Text] [Related]

  • 40. Fibrinogen 'Leuven', another genetic variant.
    Verhaeghe R, Verstraete M, Vermylen J, Vermylen C.
    Br J Haematol; 1974 Mar 05; 26(3):421-33. PubMed ID: 4852043
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.